Recent Advances in the Treatment of Chronic GVHD: ASH 2024 - Episode 1
Understanding Graft-VS-Host Disease (GVHD) Basics
Panelists discuss how graft-vs-host disease (GVHD) is a complex immune-mediated condition, highlighting the differences between acute and chronic GVHD, the associated risk factors, prognosis, and the impact of increased cyclophosphamide use on the clinical presentation of the disease.
Video content above is prompted by the following:
- Let’s talk about GVHD – what is it?
- Please walk us through the difference between acute and chronic GVHD.
- What are some risk factors associated with GvHDGVHD? What is the prognosis?
- What changes in clinical presentation of GVHD might you see with increased used of cyclophosphamide?
Related Content:
